Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123,180,519
-
Total 13F shares
-
23,812,013
-
Share change
-
+518,546
-
Total reported value
-
$25,000,000
-
Price per share
-
$1.05
-
Number of holders
-
51
-
Value change
-
+$512,936
-
Number of buys
-
17
-
Number of sells
-
17
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q4 2016
As of 31 Dec 2016 CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) had 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 23,812,013 shares of stock of the company.
Largest 10 holders included Broadfin Capital, LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Point72 Asset Management, L.P., venBio Select Advisor LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., TANAKA CAPITAL MANAGEMENT INC, BlackRock Institutional Trust Company, N.A., GEODE CAPITAL MANAGEMENT, LLC, and MILLENNIUM MANAGEMENT LLC.
This table shows 51 institutional shareholders of the security as of 31 Dec 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.